Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05003076Phase 1Completed
Phase 1, randomised trial of methamphetamine (2 arms), sponsored by University of Chicago. Primary endpoint: Drug Effects Questionnaire at Day 3. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05003076.